Evaluation of immune function under conversion from Prograf to Advagraf in living donor liver transplantation

2013 ◽  
Vol 18 ◽  
pp. 293-298 ◽  
Author(s):  
Susumu Eguchi
Keyword(s):  
Liver Transplantation ◽  
Immune Function ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Donor Liver ◽  
Donor Liver Transplantation

Evaluation of the immune function assay in pediatric living donor liver transplantation

2014 ◽  
Vol 19 (2) ◽  
pp. 144-152 ◽  
Author(s):  
Akinari Fukuda ◽  
Ken-Ichi Imadome ◽  
Seisuke Sakamoto ◽  
Takanobu Shigeta ◽  
Hajime Uchida ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Immune Function ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Donor Liver ◽  
Donor Liver Transplantation

scholarly journals Relationship between immune function recovery and infectious complications in patients following living donor liver transplantation

2016 ◽  
Vol 46 (9) ◽  
pp. 908-915 ◽  
Author(s):  
Shinichiro Kobayashi ◽  
Akihiko Soyama ◽  
Mitsuhisa Takatsuki ◽  
Masaaki Hidaka ◽  
Tomohiko Adachi ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Immune Function ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Infectious Complications ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Function Recovery

Adult-to-Adult Living-Donor Liver Transplantation

Swiss Surgery ◽  
2003 ◽  
Vol 9 (5) ◽  
pp. 227-236 ◽  
Author(s):  
Majno ◽  
Mentha ◽  
Berney ◽  
Bühler ◽  
Giostra ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Therapeutic Option ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Multidisciplinary Program ◽  
First Case ◽  
Living Donor Transplantation ◽  
The Right

Living donor liver transplantation is a relatively new procedure in which the right side of the liver is harvested in a healthy donor and transplanted into a recipient. After the first case in 1994, over 3000 cases have been done worldwide. This review summarizes the reasons why the procedure is needed, describes its main technical aspects, highlights the boundaries in which it can be done safely, summarizes the current experience worldwide and describes the main points of the program in our unit. We argue that living-donor transplantation is a viable alternative to a long time on the waiting list for several patients, and it can be performed safely and successfully provided that all precautions are undertaken to minimize the risks in the donor and to increase the chances of a good outcome in the recipients. If these prerequisites are met, and within the framework of a structured multidisciplinary program, we believe that living-donor liver transplantation should be funded by health insurances as a recognized therapeutic option.

Sign in / Sign up

Export Citation Format

Share Document